Evidence map

ReviewFrontiers in immunology2025

Targeting E3 ubiquitin ligases: a new frontier in idiopathic pulmonary fibrosis treatment.

Kun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40901482